B.U Technology Logo

B.U Technology

Commercializes university research via IP management, licensing, and new venture creation.

230980 | KO

Overview

Corporate Details

ISIN(s):
KR7230980005
LEI:
Country:
South Korea
Address:
부산광역시 강서구 명지국제2로28번길 34 에코팰리스 318호, 부산광역시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Boston University's Office of Technology Development (OTD) facilitates the commercialization of inventions and discoveries emerging from the university's research community. The office's primary objective is to translate groundbreaking research into market-ready applications by fostering collaborations between BU inventors and the entrepreneurial and industrial ecosystems. Key services include intellectual property management, patenting, technology licensing, and providing comprehensive support for the formation of new ventures. The OTD also connects industry partners with university researchers and offers education, tools, and mentorship to faculty, students, and alumni across sectors including life sciences, medical technology, and engineering.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 00:00
Legal Proceedings Report
[기재정정]회생절차개시결정
Korean 12.5 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.7 MB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-08-14 00:00
Audit Report / Information
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 13.5 KB
2025-08-14 00:00
Regulatory News Service
기타시장안내 (투자주의 환기종목 지정사유 추가 관련 시장조치 미진행)
Korean 3.4 KB
2025-08-13 00:00
Legal Proceedings Report
[기재정정]회생절차개시결정
Korean 12.2 KB
2025-07-04 00:00
Legal Proceedings Report
기타경영사항(자율공시) (상장폐지결정 효력정지 등 가처분 신청)
Korean 6.3 KB
2025-07-04 00:00
Delisting Announcement
기타시장안내 (정리매매 보류 관련)
Korean 2.8 KB
2025-07-04 00:00
Delisting Announcement
주권매매거래정지 (투자자 보호)
Korean 4.6 KB
2025-07-03 00:00
Legal Proceedings Report
[기재정정]회생절차개시결정
Korean 11.7 KB
2025-07-03 00:00
Delisting Announcement
기타시장안내 (기업심사위원회 심의·의결 결과 안내)
Korean 2.7 KB
2025-07-03 00:00
Delisting Announcement
주권매매거래정지해제 (상장폐지에 따른 정리매매 개시)
Korean 4.4 KB
2025-06-02 00:00
Legal Proceedings Report
기타시장안내 (기업심사위원회 개최기한 연장안내)
Korean 3.7 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.4 MB
2025-05-02 00:00
Legal Proceedings Report
기타시장안내 (개선계획 이행내역서 제출에 따른 안내)
Korean 3.1 KB

Automate Your Workflow. Get a real-time feed of all B.U Technology filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for B.U Technology

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for B.U Technology via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Qurient Co., Ltd. Logo
Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.
South Korea
115180
Rafael Holdings, Inc. Logo
Invests in and develops novel therapeutics for cancer and rare diseases.
United States of America
RFL
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan
4579
Recruit Holdings Co., Ltd. Logo
Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.
Japan
6098
RELMADA THERAPEUTICS, INC. Logo
A clinical-stage biotech developing novel therapies for CNS diseases and oncology.
United States of America
RLMD
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan
4889
Rentracks CO.,LTD. Logo
A pay-per-performance ad network with a closed ASP and comprehensive web consulting services.
Japan
6045
Replimune Group, Inc. Logo
Clinical-stage biotech developing oncolytic immunotherapies to treat a broad range of cancers.
United States of America
REPL
ReproCELL Incorporated Logo
Offers stem cell tech, gene editing & drug discovery services for preclinical/clinical research.
Japan
4978
RESEARCH FRONTIERS INC Logo
Develops and licenses smart glass tech for instant light, UV, and heat control.
United States of America
REFR

Talk to a Data Expert

Have a question? We'll get back to you promptly.